Oriel Therapeutics Inc. – Receives 4th US Patent

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Oriel Therapeutics today announced that the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent Number 7,377,277, issue date May 27, 2008, for dry powder dose filling systems and methods.
MORE ON THIS TOPIC